The Collapse of Infectious Disease Diagnoses Commonly Due to Communicable Respiratory Pathogens During the Coronavirus Disease 2019 Pandemic: A Time Series and Hierarchical Clustering Analysis.

COVID-19 healthcare delivery infection pandemic

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 30 12 2021
accepted: 16 04 2022
entrez: 6 7 2022
pubmed: 7 7 2022
medline: 7 7 2022
Statut: epublish

Résumé

Nonpharmaceutical interventions such as physical distancing and mandatory masking were adopted in many jurisdictions during the coronavirus disease 2019 pandemic to decrease spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We determined the effects of these interventions on incidence of healthcare utilization for other infectious diseases. Using a healthcare administrative dataset, we employed an interrupted time series analysis to measure changes in healthcare visits for various infectious diseases across the province of Ontario, Canada, from January 2017 to December 2020. We used a hierarchical clustering algorithm to group diagnoses that demonstrated similar patterns of change through the pandemic months. We found that visits for infectious diseases commonly caused by communicable respiratory pathogens (eg, acute bronchitis, acute sinusitis) formed distinct clusters from diagnoses that often originate from pathogens derived from the patient's own flora (eg, urinary tract infection, cellulitis). Moreover, infectious diagnoses commonly arising from communicable respiratory pathogens (hierarchical cluster 1: highly impacted diagnoses) were significantly decreased, with a rate ratio (RR) of 0.35 (95% confidence interval [CI], .30-.40; Public health measures to curtail the incidence of SARS-CoV-2 were widely effective against other communicable respiratory infectious diseases with similar modes of transmission but had little effect on infectious diseases not strongly dependent on person-to-person transmission.

Sections du résumé

Background UNASSIGNED
Nonpharmaceutical interventions such as physical distancing and mandatory masking were adopted in many jurisdictions during the coronavirus disease 2019 pandemic to decrease spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We determined the effects of these interventions on incidence of healthcare utilization for other infectious diseases.
Methods UNASSIGNED
Using a healthcare administrative dataset, we employed an interrupted time series analysis to measure changes in healthcare visits for various infectious diseases across the province of Ontario, Canada, from January 2017 to December 2020. We used a hierarchical clustering algorithm to group diagnoses that demonstrated similar patterns of change through the pandemic months.
Results UNASSIGNED
We found that visits for infectious diseases commonly caused by communicable respiratory pathogens (eg, acute bronchitis, acute sinusitis) formed distinct clusters from diagnoses that often originate from pathogens derived from the patient's own flora (eg, urinary tract infection, cellulitis). Moreover, infectious diagnoses commonly arising from communicable respiratory pathogens (hierarchical cluster 1: highly impacted diagnoses) were significantly decreased, with a rate ratio (RR) of 0.35 (95% confidence interval [CI], .30-.40;
Conclusions UNASSIGNED
Public health measures to curtail the incidence of SARS-CoV-2 were widely effective against other communicable respiratory infectious diseases with similar modes of transmission but had little effect on infectious diseases not strongly dependent on person-to-person transmission.

Identifiants

pubmed: 35791356
doi: 10.1093/ofid/ofac205
pii: ofac205
pmc: PMC9047204
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofac205

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

PLoS One. 2021 Jun 18;16(6):e0253451
pubmed: 34143839
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
CMAJ. 2021 Feb 8;193(6):E200-E210
pubmed: 33558406
Clin Infect Dis. 2021 Jun 15;72(12):2199-2202
pubmed: 32986804
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
Commun Dis Intell (2018). 2021 Jan 29;45:
pubmed: 33573536
Clin Infect Dis. 2021 Jun 15;72(12):2076-2078
pubmed: 33038221
J Math Ind. 2020;10(1):15
pubmed: 32501416
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Lancet Public Health. 2020 Jul;5(7):e375-e385
pubmed: 32502389
Clin Infect Dis. 2021 Jan 27;72(2):319-322
pubmed: 33501967
Eur J Dent. 2020 Dec;14(S 01):S140-S145
pubmed: 32882740
J Infect Dis. 2021 Jul 2;224(1):9-13
pubmed: 33606027

Auteurs

Ali Zhang (A)

Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.

Matthew D Surette (MD)

Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.

Kevin L Schwartz (KL)

Public Health Ontario, Toronto, Ontario, Canada.

James I Brooks (JI)

Public Health Agency of Canada, Ottawa, Ontario, Canada.

Dawn M E Bowdish (DME)

Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.

Roshanak Mahdavi (R)

ICES, Toronto, Ontario, Canada.

Douglas G Manuel (DG)

ICES, Toronto, Ontario, Canada.

Robert Talarico (R)

ICES, Toronto, Ontario, Canada.

Nick Daneman (N)

Public Health Ontario, Toronto, Ontario, Canada.

Jayson Shurgold (J)

Public Health Agency of Canada, Ottawa, Ontario, Canada.

Derek MacFadden (D)

ICES, Toronto, Ontario, Canada.

Classifications MeSH